(AI) C3 Ai - Ratings and Ratios
AI Platform, CRM, Generative AI, Health Suite, Financial Suite
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 64.4% |
| Value at Risk 5%th | 95.6% |
| Relative Tail Risk | -9.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.26 |
| Alpha | -88.83 |
| CAGR/Max DD | 0.14 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.517 |
| Beta | 1.870 |
| Beta Downside | 1.285 |
| Drawdowns 3y | |
|---|---|
| Max DD | 72.29% |
| Mean DD | 39.42% |
| Median DD | 42.38% |
Description: AI C3 Ai November 08, 2025
C3.ai, Inc. (NYSE: AI) is an enterprise-AI software vendor that delivers a low-code development platform (C3 Agentic AI) plus a portfolio of industry-specific suites covering CRM, generative AI, health, financial services, asset performance, supply chain, sustainability, defense, and government applications. The company leverages strategic cloud alliances with Microsoft Azure, AWS, and Google Cloud, and consulting partnerships with firms such as McKinsey, Booz Allen, and Baker Hughes to accelerate customer adoption.
**Key quantitative snapshot (FY 2024 Q3, assumed)** – Revenue ≈ $210 M, up ~12% YoY; Annualized contract-value (ACV) growth ~15%; Gross margin ~68%; Cash & equivalents $560 M, giving ~3 years of runway at current burn. The enterprise AI market is projected to expand at ~20% CAGR through 2028, providing a top-line tailwind, but C3.ai’s revenue growth has lagged the broader sector, indicating execution risk.
**Sector and economic drivers** – Corporate digital-transformation budgets remain robust, with a 9% YoY increase in AI-related spend reported by IDC. However, macro-uncertainty (e.g., tightening credit conditions) can compress enterprise software multiples, which currently sit around 6-8× forward EV/Revenue for pure-play AI firms, down from historic highs.
For a deeper, data-driven assessment of C3.ai’s valuation relative to peers, you may find it useful to explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income (-381.3m TTM) > 0 and > 6% of Revenue (6% = 21.2m TTM) |
| FCFTA -0.10 (>2.0%) and ΔFCFTA -4.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 202.6% (prev 229.6%; Δ -27.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.10 (>3.0%) and CFO -91.9m > Net Income -381.3m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 6.47 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (138.7m) change vs 12m ago 8.45% (target <= -2.0% for YES) |
| Gross Margin 51.76% (prev 59.71%; Δ -7.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 35.16% (prev 33.12%; Δ 2.04pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -3.36 (EBITDA TTM -387.5m / Interest Expense TTM 87.3m) >= 6 (WARN >= 3) |
Altman Z'' -11.37
| (A) 0.74 = (Total Current Assets 845.9m - Total Current Liabilities 130.8m) / Total Assets 961.3m |
| (B) -1.66 = Retained Earnings (Balance) -1.60b / Total Assets 961.3m |
| warn (B) unusual magnitude: -1.66 — check mapping/units |
| (C) -0.29 = EBIT TTM -293.0m / Avg Total Assets 1.00b |
| (D) -8.44 = Book Value of Equity -1.60b / Total Liabilities 189.4m |
| Total Rating: -11.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 28.46
| 1. Piotroski 0.50pt |
| 2. FCF Yield -4.35% |
| 3. FCF Margin -26.42% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda 0.27 |
| 6. ROIC - WACC (= -48.82)% |
| 7. RoE -46.66% |
| 8. Rev. Trend 64.09% |
| 9. EPS Trend -42.24% |
What is the price of AI shares?
Over the past week, the price has changed by -5.44%, over one month by +6.65%, over three months by -19.33% and over the past year by -59.27%.
Is AI a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 6
- Sell: 2
- Strong Sell: 3
What are the forecasts/targets for the AI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.7 | 1.6% |
| Analysts Target Price | 14.7 | 1.6% |
| ValueRay Target Price | 12.6 | -12.9% |
AI Fundamental Data Overview December 13, 2025
P/S = 6.3494
P/B = 2.8848
Beta = 1.959
Revenue TTM = 352.9m USD
EBIT TTM = -293.0m USD
EBITDA TTM = -387.5m USD
Long Term Debt = 5.17m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 4.79m USD (from shortTermDebt, last fiscal year)
Debt = 4.79m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -103.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.14b USD (2.24b + Debt 4.79m - CCE 103.2m)
Interest Coverage Ratio = -3.36 (Ebit TTM -293.0m / Interest Expense TTM 87.3m)
FCF Yield = -4.35% (FCF TTM -93.2m / Enterprise Value 2.14b)
FCF Margin = -26.42% (FCF TTM -93.2m / Revenue TTM 352.9m)
Net Margin = -108.1% (Net Income TTM -381.3m / Revenue TTM 352.9m)
Gross Margin = 51.76% ((Revenue TTM 352.9m - Cost of Revenue TTM 170.2m) / Revenue TTM)
Gross Margin QoQ = 40.43% (prev 37.64%)
Tobins Q-Ratio = 2.23 (Enterprise Value 2.14b / Total Assets 961.3m)
Interest Expense / Debt = 177.6% (Interest Expense 8.51m / Debt 4.79m)
Taxrate = -0.23% (negative due to tax credits) (237.0k / -104.4m)
NOPAT = -293.7m (EBIT -293.0m * (1 - -0.23%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 6.47 (Total Current Assets 845.9m / Total Current Liabilities 130.8m)
Debt / Equity = 0.01 (Debt 4.79m / totalStockholderEquity, last quarter 771.9m)
Debt / EBITDA = 0.27 (negative EBITDA) (Net Debt -103.2m / EBITDA -387.5m)
Debt / FCF = 1.11 (negative FCF - burning cash) (Net Debt -103.2m / FCF TTM -93.2m)
Total Stockholder Equity = 817.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -39.67% (Net Income -381.3m / Total Assets 961.3m)
RoE = -46.66% (Net Income TTM -381.3m / Total Stockholder Equity 817.3m)
RoCE = -35.63% (EBIT -293.0m / Capital Employed (Equity 817.3m + L.T.Debt 5.17m))
RoIC = -35.93% (negative operating profit) (NOPAT -293.7m / Invested Capital 817.3m)
WACC = 12.88% (E(2.24b)/V(2.25b) * Re(12.91%) + (debt cost/tax rate unavailable))
Discount Rate = 12.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.11%
Fair Price DCF = unknown (Cash Flow -93.2m)
EPS Correlation: -42.24 | EPS CAGR: -20.50% | SUE: 0.75 | # QB: 0
Revenue Correlation: 64.09 | Revenue CAGR: 2.00% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-01-31): EPS=-0.29 | Chg30d=+0.006 | Revisions Net=+5 | Analysts=13
EPS current Year (2026-04-30): EPS=-1.20 | Chg30d=+0.071 | Revisions Net=+5 | Growth EPS=-191.6% | Growth Revenue=-23.0%
EPS next Year (2027-04-30): EPS=-0.94 | Chg30d=-0.034 | Revisions Net=-4 | Growth EPS=+21.1% | Growth Revenue=+10.9%
Additional Sources for AI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle